Skip to content

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp

Other financials

Income statement

See full
Revenue$47.1M-24.0%
Gross profit$22.1M-12.8%
Operating income-$360.0K+62.2%
Net income-$381.0K+61.6%
EPS (diluted)-$0.03+62.5%

Balance sheet

See full
Cash & equivalents$21.4M-8.5%
Total debt$32.4M-2.7%
Total equity$165.9M-6.6%
Total assets$226.6M-8.0%

Cash flow

See full
Operating cash flow$11.4M+47.0%
CapEx$41.0K-92.7%
Free cash flow$11.4M

Valuation

See full
Market cap$146.83M-3.8%
Enterprise value$157.78M-2.9%
P/S0.8×+0.1×

Profitability

See full
Gross margin44.7%+0.1pp
Operating margin-4.7%-4.8pp
Net margin-4.8%-4.9pp
FCF margin2.2%

Returns & leverage

See full
Return on equity-5.4%-5.4pp
Debt / equity0.2×0.0×
Current ratio5.4×+0.8×